United Therapeutics Stock
Price
Target price
€251.50
€251.50
0.080%
0.2
0.080%
€287.40
18:54 / Tradegate
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
United Therapeutics Stock
There is nearly no change for the United Therapeutics stock today. Compared to yesterday it only changed by €0.20.
With 19 Buy predictions and not the single Sell prediction the community is currently very high on United Therapeutics.
With a target price of 287 € there is a slightly positive potential of 14.12% for United Therapeutics compared to the current price of 251.5 €.
Pros and Cons of United Therapeutics in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 0.080% | -0.357% | 14.227% | 26.919% | 26.759% | 65.329% | 227.640% |
| Ironwood Pharmaceuticals | -1.800% | -6.034% | -26.351% | -46.040% | -46.569% | -44.388% | - |
| Novocure Ltd | -1.550% | 5.435% | 80.694% | -68.865% | 49.492% | -86.241% | - |
| Iovance Biotherapeutics Inc. | -0.200% | -2.040% | -15.122% | 31.330% | 18.110% | -40.117% | - |
Comments
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at JPMorgan Chase & Co. from $280.00 to $300.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Oppenheimer Holdings Inc. from $375.00 to $400.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics Co. (NASDAQ: UTHR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $300.00 price target on the stock.
Show more
Ratings data for UTHR provided by MarketBeat